Se

Prescription products · Product label record

Septaforce drug information

BAPTISIA TINCTORIA, ECHINACEA (ANGUSTIFOLIA), ARSENICUM ALBUM, CHININUM SULPHURICUM, CROTALUS HORRIDUS, LACHESIS MUTUS, SECALE CORNUTUM, TARENTULA CUBENSIS, LATRODECTUS MACTANS, ANTHRACINUM, LOXOSCELES RECLUSA
BioActive Nutritional, Inc. · ORAL

Product NDC: 43857-0620

Join the community
CommunityExperiencesReviewsDrug database
Source label information, not individualized medical advice. This record applies to the product and labeler shown below. Compare the exact formulation, strength and country with your package and the current source label.
Generic nameBAPTISIA TINCTORIA, ECHINACEA (ANGUSTIFOLIA), ARSENICUM ALBUM, CHININUM SULPHURICUM, CROTALUS HORRIDUS, LACHESIS MUTUS, SECALE CORNUTUM, TARENTULA CUBENSIS, LATRODECTUS MACTANS, ANTHRACINUM, LOXOSCELES RECLUSA
Labeler / manufacturerBioActive Nutritional, Inc.
RouteORAL
Drug classDrug class not supplied in source label
Product NDC43857-0620
Label effective date2024-10-18

Official product label reference

Septaforce — BioActive Nutritional, Inc.

This page contains 8 source sections for BAPTISIA TINCTORIA, ECHINACEA (ANGUSTIFOLIA), ARSENICUM ALBUM, CHININUM SULPHURICUM, CROTALUS HORRIDUS, LACHESIS MUTUS, SECALE CORNUTUM, TARENTULA CUBENSIS, LATRODECTUS MACTANS, ANTHRACINUM, LOXOSCELES RECLUSA, oral route. Label set 1fc4058f-b1e5-461b-9027-7bc8761ab48a, version 2.

Retrieved 2026-10-02 · openFDA dataset updated 2026-10-02 · Check the current DailyMed label

Label records can cover multiple strengths or package sizes. A label listing does not by itself establish FDA approval or current market availability. Check the source and application history for this specific product.

Uses described in the label

INDICATIONS: For temporary relief of constricted feeling of the chest, palpitations with anxiety, purplish hue, burning, stinging pains, inflammation of connective tissues.

Purpose

INDICATIONS: For temporary relief of constricted feeling of the chest, palpitations with anxiety, purplish hue, burning, stinging pains, inflammation of connective tissues.
Dosage and administration — label text
DIRECTIONS: 10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS: If pregnant or breast-feeding, ask a health care professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in cool, dry place.
Active ingredient
ACTIVE INGREDIENTS: Baptisia Tinctoria 3X, Echinacea (Angustifolia) 3X, Arsenicum Album 12X, Chininum Sulphuricum 12X, Crotalus Horridus 12X, Lachesis Mutus 12X, Secale Cornutum 12X, Tarentula Cubensis 12X, Latrodectus Mactans 12X, 30X, Anthracinum 33X, Loxosceles Reclusa 15C.
Child safety
KEEP OUT OF REACH OF CHILDREN: Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Inactive ingredient
INACTIVE INGREDIENTS: Demineralized Water, 25% Ethanol
Questions
QUESTIONS: Distributed by: BioActive Nutritional, Inc. 1803 N. Wickham Rd. Melbourne, FL 32935 bioactivenutritional.com

Official sources and product identifiers

Substances listed: BAPTISIA TINCTORIA ROOT, ECHINACEA ANGUSTIFOLIA WHOLE, ARSENIC TRIOXIDE, QUININE SULFATE, CROTALUS HORRIDUS HORRIDUS VENOM, LACHESIS MUTA VENOM, CLAVICEPS PURPUREA SCLEROTIUM, CITHARACANTHUS SPINICRUS, LATRODECTUS MACTANS, BACILLUS ANTHRACIS IMMUNOSERUM RABBIT, LOXOSCELES RECLUSA

Package NDC codes

43857-0620-1

Further research and background

These are external searches for related information. Research, encyclopedia and news articles have not been imported into this product record.

Coverage and corrections

The text is extracted from a US structured product label. Tables are represented as text where supplied; formatting and illustrations may be lost. A missing section does not mean a risk is absent. This reference has not been independently reviewed by a clinician and is not a live safety-alert service.

Source retrieved 2026-10-02. Read the source policy.